PD64-10 ELEVEN YEARS OF EXPERIENCE WITH UPPER TRACT UROTHELIAL CARCINOMA: SURVIVAL AND RENAL FUNCTION AFTER KIDNEY SPARING SURGERY VERSUS RADICAL NEPHROURETERECTOMY

You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy VI (PD64)1 Sep 2021PD64-10 ELEVEN YEARS OF EXPERIENCE WITH UPPER TRACT UROTHELIAL CARCINOMA: SURVIVAL AND RENAL FUNCTION AFTER KIDNEY SPARING SURGERY VERSUS RADICAL NEPHROURETERECTOMY Nora Hendriks, Joyce Baard, Harrie P. Beerlage, Barbara M.A. Schout, Rob C.M. Pelger, Klara SG Doherty, and Guido M. Kamphuis HendriksNora Hendriks More articles by this author , BaardJoyce Baard BeerlageHarrie Beerlage SchoutBarbara Schout PelgerRob Pelger DohertyKlara Doherty KamphuisGuido View All Author Informationhttps://doi.org/10.1097/JU.0000000000002108.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION OBJECTIVE: The gold standard treatment for upper urinary tract urothelial carcinoma (UTUC) is radical nephroureterectomy (RNU). Criteria qualify kidney sparing surgery (KSS) become less strict in consecutive guidelines, thereby gaining a more prominent position. In study we compare the oncological outcomes renal function patients with UTUC treated KSS RNU tertiary referral center. METHODS: retrospective cohort study, included 174 adult histopathological confirmed non-metastatic from 2010 through 2020 either or (segmental ureter resection, ureterorenoscopy, percutaneous tumor resection). Risk stratification was based on current EAU guidelines UTUC. RESULTS: arm had larger population (86.2%) high risk tumors compared (74.4%; p = 0.030). Recurrence Free Survival (RFS), Metastasis (MFS), Overall (OS) Cancer Specific (CSS) concerning are presented figure 1. Within 73.2% did not an imperative reason choice treatment. MFS (p 0.004), CSS 0.027) OS 0.033) were all significantly higher when comparing both groups (figure 2). There no significant long-term differences function, except three months one year after intervention 3). CONCLUSIONS: Current indicate that best RNU. conclude MFS, as well outside scope guidelines. Source Funding: Cure © 2021 American Urological Association Education Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1148-e1149 Advertisement Copyright & Permissions© Inc.MetricsAuthor Information Expand Loading ...